Skip to main content

BANK OF AMERICA CORP /DE/

Bank

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 70858 CHARLOTTE, NC

Position in RYTM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$36,136,932
-$18,538,234 QoQ
Shares Held
325,470
-48.2% QoQ
Ownership
0.473%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in RYTM Over Time

Shares Held

Position Value (USD)

Derivatives in RYTM

reported options exposure · as of Dec 31, 2024
CallValue
$363,870
CallShares
6,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. RYTM ranks #62 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RYTM

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $36,136,932 325,470
2026-03-31 $54,675,166 628,667
2025-12-31 $24,028,763 224,484
2025-09-30 $23,545,814 233,150
2025-06-30 $14,037,782 222,152
2025-03-31 $5,919,501 111,752
2024-12-31 $363,870 6,500
2024-12-31 $5,849,236 104,488
2024-09-30 $539,617 10,300
2024-09-30 $5,566,434 106,250
2024-06-30 $3,779,283 92,043
2024-03-31 $4,814,568 111,114
2023-12-31 $3,211,921 69,870
2023-09-30 $2,527,318 110,243
2023-06-30 $2,310,544 140,118
2023-03-31 $6,416,439 359,666
2022-12-31 $7,750,375 266,153
2022-09-30 $5,351,020 218,409
2022-06-30 $203,812 49,112
2022-03-31 $456,362 39,615
2021-12-31 $1,223,894 122,635
2021-09-30 $2,670,284 204,463
2021-06-30 $2,343,293 119,678
2021-03-31 $2,264,019 106,442
2020-12-31 $2,680,424 90,159
2020-09-30 $6,032,493 278,380
2020-06-30 $5,712,322 256,158
2020-03-31 $707,865 46,509